Insider Transactions in Q2 2022 at Boston Scientific Corp (BSX)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 24
2022
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
7,500
-5.36%
|
$285,000
$38.0 P/Share
|
|
May 16
2022
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Bona fide gift
|
Direct |
26
-0.02%
|
-
|
|
May 16
2022
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
7,500
-5.09%
|
$292,500
$39.43 P/Share
|
|
May 05
2022
|
Charles J Dockendorff Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,877
+22.21%
|
-
|
|
May 05
2022
|
Nelda J Connors Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,877
+23.4%
|
-
|
|
May 05
2022
|
Edward J Ludwig Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,877
+10.54%
|
-
|
|
May 05
2022
|
David J Roux Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,877
+6.54%
|
-
|
|
May 05
2022
|
John E Sununu Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,877
+9.62%
|
-
|
|
May 05
2022
|
David S Wichmann Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,613
+10.89%
|
-
|
|
May 05
2022
|
Ellen M Zane Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,877
+10.47%
|
-
|
|
May 01
2022
|
Meghan Scanlon SVP,Pres,Urology Pelvic Health |
SELL
Payment of exercise price or tax liability
|
Direct |
606
-2.42%
|
$25,452
$42.11 P/Share
|
|
May 01
2022
|
Meghan Scanlon SVP,Pres,Urology Pelvic Health |
BUY
Exercise of conversion of derivative security
|
Direct |
2,062
+7.6%
|
-
|
|
Apr 20
2022
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
9,645
-8.04%
|
$443,670
$46.5 P/Share
|
|
Apr 19
2022
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
10,989
-8.39%
|
$494,505
$45.5 P/Share
|
|
Apr 14
2022
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
7,500
-4.84%
|
$330,000
$44.47 P/Share
|
|
Apr 01
2022
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
SELL
Open market or private sale
|
Direct |
2,779
-10.67%
|
$125,055
$45.0 P/Share
|
|
Apr 01
2022
|
Scott Olson SVP & Pres, CRM, Diagnostics |
SELL
Open market or private sale
|
Direct |
700
-4.6%
|
$30,800
$44.55 P/Share
|